Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 90, Issue 6, Pages 777-790
Publisher
Springer Nature
Online
2011-11-03
DOI
10.1038/clpt.2011.235
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples
- (2011) Jeremy A. Rassen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- What We Can Learn From a Decision Model
- (2011) Mark A. Hlatky ARCHIVES OF INTERNAL MEDICINE
- Comparative Effectiveness: The Fourth Hurdle in Drug Development and a Role for Clinical Pharmacology
- (2011) P K Honig CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cardiovascular outcomes associated with a new once-weekly GLP-1 receptor agonist vs. traditional therapies for type 2 diabetes: a simulation analysis
- (2011) B. R. Peskin et al. DIABETES OBESITY & METABOLISM
- Availability of Comparative Efficacy Data at the Time of Drug Approval in the United States
- (2011) Nikolas H. Goldberg JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Developing the Sentinel System — A National Resource for Evidence Development
- (2011) Rachel E. Behrman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Utilizing Medicare claims data for real-time drug safety evaluations: is it feasible?,
- (2011) Abraham G. Hartzema et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic “matrix design”
- (2011) Jeremy A. Rassen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- An update on the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design
- (2010) Robert M. Califf et al. AMERICAN HEART JOURNAL
- Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis
- (2010) C. Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- Portfolio Selection and Management in Pharmaceutical Research and Development: Issues and Challenges
- (2010) C Cioffe CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Trial Simulation: A Review
- (2010) N Holford et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Minimizing Bias Due to Confounding by Indication in Comparative Effectiveness Research
- (2010) Bruce M. Psaty et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Dabigatran and rivaroxaban for prevention of venous thromboembolism - systematic review and adjusted indirect comparison
- (2010) Y. K. Loke et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Instrumental variable methods in comparative safety and effectiveness research
- (2010) M. Alan Brookhart et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A basic study design for expedited safety signal evaluation based on electronic healthcare data
- (2010) Sebastian Schneeweiss PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Multiple Imputation for Missing Laboratory Data: An Example from Infectious Disease Epidemiology
- (2009) Zuber D. Mulla et al. ANNALS OF EPIDEMIOLOGY
- A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview
- (2009) J. A. Singh et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
- (2009) Sebastian Schneeweiss et al. EPIDEMIOLOGY
- Impact of Asthma Controller Medications on Clinical, Economic, and Patient-Reported Outcomes
- (2009) Hiangkiat Tan et al. MAYO CLINIC PROCEEDINGS
- Instrumental Variable Analysis for Estimation of Treatment Effects With Dichotomous Outcomes
- (2008) J. A. Rassen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- The risk of infection associated with tumor necrosis factor α antagonists: Making sense of epidemiologic evidence
- (2008) Daniel H. Solomon et al. ARTHRITIS AND RHEUMATISM
- The importance of anaemia in diagnosing colorectal cancer: a case–control study using electronic primary care records
- (2008) W Hamilton et al. BRITISH JOURNAL OF CANCER
- Use of Ezetimibe in the United States and Canada
- (2008) Cynthia A. Jackevicius et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started